Literature DB >> 26252119

Microbial cocktails join fecal transplants in IBD treatment trials.

Mark Ratner.   

Abstract

Mesh：

Year:  2015        PMID： 26252119     DOI： 10.1038/nbt0815-787

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

1.  Drugging the gut microbiome.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2015-03       Impact factor: 54.908

2.  OpenBiome remains open to serve the medical community.

Authors:  Mark Smith; Zain Kassam; Carolyn Edelstein; James Burgess; Eric Alm
Journal:  Nat Biotechnol       Date:  2014-09       Impact factor: 54.908

3.  Fecal transplantation poses dilemma for FDA.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2014-05       Impact factor: 54.908

4.  Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.

Authors:  Paul Moayyedi; Michael G Surette; Peter T Kim; Josie Libertucci; Melanie Wolfe; Catherine Onischi; David Armstrong; John K Marshall; Zain Kassam; Walter Reinisch; Christine H Lee
Journal:  Gastroenterology       Date:  2015-04-07       Impact factor: 22.682
  4 in total
  13 in total

1.  Seres's pioneering microbiome drug fails mid-stage trial.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2016-10-11       Impact factor: 54.908

Review 2.  Microbiome therapeutics - Advances and challenges.

Authors:  Mark Mimee; Robert J Citorik; Timothy K Lu
Journal:  Adv Drug Deliv Rev       Date:  2016-05-05       Impact factor: 15.470

3.  A Summary of the Fifth Annual Virology Education HIV Microbiome Workshop.

Authors:  Scott Sherrill-Mix; Kaleigh Connors; Grace M Aldrovandi; Jason M Brenchley; Charles Boucher; Frederic D Bushman; Ronald G Collman; Satya Dandekar; Nichole R Klatt; Laurel A Lagenaur; Roger Paredes; Gilda Tachedjian; Jim A Turpin; Alan L Landay; Mimi Ghosh
Journal:  AIDS Res Hum Retroviruses       Date:  2020-09-07       Impact factor: 2.205

Review 4.  Gut microbiota and its implications in small bowel transplantation.

Authors:  Chenyang Wang; Qiurong Li; Jieshou Li
Journal:  Front Med       Date:  2018-03-09       Impact factor: 4.592

Review 5.  Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.

Authors:  R Balfour Sartor; Gary D Wu
Journal:  Gastroenterology       Date:  2016-10-18       Impact factor: 22.682

Review 6.  The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.

Authors:  Shahla Abdollahi-Roodsaz; Steven B Abramson; Jose U Scher
Journal:  Nat Rev Rheumatol       Date:  2016-06-03       Impact factor: 20.543

Review 7.  Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity.

Authors:  Christian Carlucci; Elaine O Petrof; Emma Allen-Vercoe
Journal:  EBioMedicine       Date:  2016-10-01       Impact factor: 8.143

Review 8.  Emerging Trends in "Smart Probiotics": Functional Consideration for the Development of Novel Health and Industrial Applications.

Authors:  Racha El Hage; Emma Hernandez-Sanabria; Tom Van de Wiele
Journal:  Front Microbiol       Date:  2017-09-29       Impact factor: 5.640

Review 9.  Bugging inflammation: role of the gut microbiota.

Authors:  Sj Shen; Connie Hy Wong
Journal:  Clin Transl Immunology       Date:  2016-04-15

10.  Cross-Kingdom Similarities in Microbiome Ecology and Biocontrol of Pathogens.

Authors:  Gabriele Berg; Robert Krause; Rodrigo Mendes
Journal:  Front Microbiol       Date:  2015-11-25       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.